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ABSTRACT
Protective Effects of Milk Phospholipids against UV-induced DNA Damage in Human
Skin Cells
Lan-Anh Ngoc Nguyen

Skin cancer is the most common type of cancer in the US. The American Academy of
Dermatology estimated that more than 3.5 million new cases of skin cancer are diagnosed in the
US each year and 1 in 5 Americans will likely to develop skin cancer in their life time. Most
cases of skin cancer are caused by exposure to ultraviolet (UV) radiation from the sun. Some of
the most common sunscreen ingredients are unstable and can form harmful radicals upon
exposure to UV radiation. There is a strong clinical need for a more stable and effective
sunscreen ingredient such as bovine milk phospholipids (MP). Phospholipids were shown to
have beneficial health effects such as regulation of the inflammatory reactions, protective effects
against colon cancer, and reducing cardiovascular risk factors. Previous histology and MTT
tissue viability research studies suggested that MP act upon skin cells in a protective manner
against UV radiation.
This thesis aims to further investigate the protective effects of bovine milk phospholipids
by evaluating the expression of a UV-induced DNA damage marker, cyclin-dependent kinase
inhibitor, p21WAF1/CIP1. Western blots were used to quantify p21 expression in human
keratinocytes in four categories of samples: No-UV, UV, UV+MP, MP and in HeLa (p21
positive control). In the No-UV samples, cells were not irradiated by UV light. However, in the
UV samples, keratinocytes were exposed to a UV dosage of 10 mJ/cm2. In the UV+MP samples,
keratinocytes were first treated with 1% MP solution (w/v) in their culture media for 24 hours
iv

then exposed to a UV dosage of 10 mJ/cm2. In MP, keratinocytes were treated with 1% MP
solution in their culture media for 24 hours. Total cell proteins were extracted 24 hours post-UV
irradiation. The same amount of protein from each sample (determined by BCA assay) was
loaded into a 4-12% Bis-Tris SDS-PAGE gel, run under denaturing, non-reducing conditions
then blotted and treated with antibodies for the quantitative detection of p21 proteins. Finally,
intensities of p21 protein bands were analyzed by using ImageJ software.
Under non-reducing conditions, three p21 proteins covalently bonded with each other
showed up as 63 KDa molecules on the PVDF membrane. The UV, and HeLa samples showed a
2.28 fold, and 1.23 fold increase in p21 expression, respectively, compared with the No-UV
samples control. The MP samples showed a 0.948 fold decrease in p21 compared with the NoUV samples, and the UV+MP samples showed only a 1.13 fold increase in p21. When
comparing with the UV sample, the UV+MP sample has 50.4% less p21 expression. Less p21
expression in the UV+MP sample compare with the UV sample suggested that less DNA
damage occurred in the sample that was treated with milk phospholipids. This result strongly
suggests that 1% bovine milk phospholipids can protect skin cells from UV induced DNA
damage.

Keywords: Keratinocytes, milk phospholipids, p21, UV-induced DNA damage, skin cancer
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Chapter 1: Introduction
1.1. Skin Cancer and Its Etiology
Skin cancer is the most common type of cancer in the US. According to the American
Academy of Dermatology, more than 3.5 million new cases of skin cancer are diagnosed in the
US each year (Rogers 2010). It is also estimated that1 in 5 Americans will likely to develop skin
cancer in their life time (RS. 2010). By 2015, 1 in 50 Americans will develop melanoma, the
most serious form of skin cancer that can spread to other parts of the body (Rigel DS 2010).
Melanoma attributes for about 75% of skin cancer deaths and is estimated to cause about 9,480
American deaths in 2013. Studies about cancer incidence across different races showed that
Caucasians have five times higher in risks of developing melanoma than Hispanics and African
Americans (Society 2013). In the US, the cost for melanoma treatment was $2.36 billion in
2010 and for non-melanoma treatment was $1.5 billion in 2004 (Bickers DR 2006, A. 2007).
Skin cancer is mostly caused by exposure to ultraviolet (UV) rays. About 86% of
melanoma and 90% of nonmelanoma skin cancers are caused by exposure to UV radiation (Koh
HK 1996, Parkin DM 2011). Over the last decade, many topical sunscreen products have been
developed to reduce the effect of UV radiation on skin. Sunscreen products contain ingredients
that can absorb, reflect or scatter UV rays. Therefore, they can decrease the effect of UV
radiation on the skin and prevent skin cancer.

1.2. The Current Problem with Sunscreen Ingredients
Butylmethoxydibenzoylmethane (BMDM) and Octyle methoxycinnamate (OMC) are the
most widely used UVA and UVB filters in sunscreen products (Tarras-Wahlberg, Stenhagen et
al. 1999, Chatelain and Gabard 2001). However, they are not very stable when exposed to
1

sunlight. BMDM often decomposes under sunlight irradiation. Its photofragmentation also leads
to the formation of free radicals that are harmful to the skin (Tarras-Wahlberg, Stenhagen et al.
1999, Chatelain and Gabard 2001). There is a strong clinical need for a more stable, and
effective sunscreen ingredients. Bovine milk phospholipids, naturally derived from milk, are
very promising sunscreen ingredients.

1.3. Motivational Research Findings
Russel et al., 2010 & Achay et al., 2011 found that bovine milk phospholipids (BMP) act
upon skin cells in a protective manner against the effect of UV radiation. Milk phospholipids
incubation also induced an increase in epidermal thickening in human skin tissue equivalents,
which enhanced the protective barrier of the skin against UV radiation (Russell, Laubscher et al.
2010, Achay 2011)
Hurato-Ono et al., 2012 showed that dietary sphingomyelin (SM) concentrate, an
important phospholipid of BMC can improve epidermal functions in mice model by increasing
the epidermal hydration, ceramide content and decreasing transepidermal water loss (HarutaOno, Setoguchi et al. 2012)

1.4. Hypothesis
Bovine milk phospholipids can reduce UV-induced DNA damage in skin cells, which
protect and prevent skin cells from not developing into malignant tumors in skin cancer.

1.5. Bovine Milk Phospholipids and p21 Background
Phospholipids are found mostly in the milk fat globule membrane. Phospholipids were
shown to have beneficial health effects such as regulation of the inflammatory reactions,
2

protective effects against gastrointestinal infections and colon cancer, and reducing
cardiovascular risk factors.
Protein p21Cip1/Waf1 is a biomarker for DNA damage. P21 stops the cell cycle to repair
DNA damage before replication or induces apoptosis if the DNA damage is too extensive to
repair.

1.6. Goals and the Road Map of This Project
The goal of this project is to investigate whether or not bovine milk phospholipids can
protect skin cells from DNA damage induced by ultraviolet radiation by studying the expression
of p21Cip1/Waf1, a biomarker for DNA damage. The Western Blot assay was used to detect and
quantify the expression of protein p21 in 4 treatment groups: a control group with no milk
phospholipid and UV treatment (No UV), a group exposed to UV alone (UV), a group treated
with milk phospholipids then UV (MP+UV) and a group treated with milk phospholipids alone
(MP). The expression level of p21 corresponds to the amount of DNA damage. It was expected
that if the bovine milk phospholipids could protect skin cells from DNA damage caused by UV
radiation, the MP+UV group would have less p21 expression than the UV group.
There were three main technical challenges to accomplish the goal of this thesis project.
The first challenge was to develop a protocol to successfully induce p21 expression in
keratinocyte cells using UV light. The second challenge was to determine the minimum amount
of cells needed for each treatment so that there were sufficient extracted proteins for the
Western blot assay. Finally, the third challenge was to develop a working Western blot protocol
to show clear signals of p21 from each treatment on the PDF membrane so that researchers can

3

evaluate the effects of milk phospholipid in protecting skin cells from UV induced DNA
damage.

4

Chapter 2: Background
2.1. Skin Structure
Skin is the largest organ in the body that accounts for about 16% of the body weight (GJ
and BH 2009). The skin thickness is usually 1-2 mm; however, it varies throughout the body
depending on the location and the function (C 1998). The skin can be 0.5 mm thick at the eyelid
or 3-4 mm thick at the soles of the feet (C 1998). The skin consists of thick outer layers, a
network of sweat glands that is sensitive to temperature changes, cells that are sensitive to touch,
pain, pressure, itching, temperature and a layer of fatty tissue under the skin surface (C 1998).
The skin structure is usually divided into 3 main regions from top to bottom: the
epidermis, the dermis, and the subcutaneous tissue.
The epidermis is composed of many layers of stratified keratinised squamous epithelium
near the surface of the skin (GJ and BH 2009). It is avascular (without blood vessels), therefore
all oxygenation, metabolite provisions and removal of metabolic waste products activities of
cells in the epidermis depends on the blood vessels of the dermis (GJ and BH 2009). The
epidermis consists of four main types of cells: keratinocytes (90%), melanocytes (8%),
Langerhans cell and Merkel cells (2%) (GJ and BH 2009). The keratinocytes function as a
barrier against environmental damage such as pathogens, heat, UV radiation and water loss (GJ
and BH 2009). The melanocytes involve in the production of the skin pigment, melanin (GJ and
BH 2009). Langerhans cells are responsible for immune response and Merkel cells are involved
in the sensation of touch (GJ and BH 2009). The epidermis consists of 5 main layers from
bottom to top: the stratum basale (stratum germinativum), stratum spinosum, stratum
granulosum, stratum lucidum, and stratum corneum (S. and R. 2005). Normally, cells mature and
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divide in the bottom layer stratum basale then move up to the top layer stratum corneum, where
they are shed (GJ and BH 2009).
The stratum basale consists of keratinocytes, melanocytes and Merkel cells that are
capable of dividing (GJ and BH 2009). After mitosis, keratinocytes formed 2 daughter cells (GJ
and BH 2009). However, only 1 cell stays in the stratum basale, the other cell will move up
through other layers to the top surface of the epidermis (GJ and BH 2009). It usually takes 28
days for keratinocytes to move up and reach the top layer in an epidermis of 0.1 mm thickness
(GJ and BH 2009). The stratum basale is the nearest layer to the dermis and receives nutrients
from the blood supply of the dermis through diffusion (GJ and BH 2009). However, as
keratinocytes divide and move up away from the stratum basale, they receive less nutrition and
start to die on their way up to the top surface of the epidermis (GJ and BH 2009). These
keratinocytes cells also become more keratinised by accumulating more keratin, a fibrous protein
that protects the skin from heat, chemicals and microorganisms (GJ and BH 2009). The body
usually maintains a balance between the formation of new keratinocytes in the stratum basale
and the shedding of dead keratinocytes in the stratum corneum (GJ and BH 2009).
On average, one in every six cells in the stratum basale is melanocyte cell (C and JS
2007). Melanocytes produce melanin, a pigment that involves in the protection of the skin from
the effects of ultraviolet (UV) radiation (C and JS 2007). The melanocytes have long projections
that contain melanin granules (C and JS 2007). These projections extend and transfer melanin
granules among keratinocytes (C and JS 2007). Inside keratinocytes, these melanin granules
accumulate and form a covering around the nucleus to protect keratinocytes from UV radiation
damage (C and JS 2007). The amount of melanin in epidermal cells affects the skin color (C and
JS 2007). The more melanin is present in keratinocytes, the darker the skin is (C and JS 2007).
6

Besides keratinocytes, melanocytes, the stratum basale also contains Merkel cells (C and
JS 2007). These Merkel cells connect with a Merkel disc, a sensory neuron, to detect the
sensation of touch (C and JS 2007).

2.1.1. Stratum Spinosum Layer
The stratum spinosum layer is 5 to 12 cells thick and contains mainly keratinocytes and
Langerhans cells (Patton 2012). After each round of mitosis, one keratinocyte cell produces two
new keratinocytes in the stratum basale (Patton 2012). However, only one daughter keratinocyte
stays in the stratum basale, the other new keratinocyte moves up to the stratum spinosum layer
(GJ and BH 2009). When keratinocyte cells move into the stratum spinosum layer, they lose the
ability to divide and also become rounder and spikier in shape (Patton 2012). Keratinocyte cells
are also connected with each other via demosomes, thorn-like projection intracellular bridges.
This arrangement gives the skin its tensile strength and flexibility (Haruta-Ono, Setoguchi et al.
2012).
Besides keratinocytes, the stratum spinosum layer also contains Langerhans cells, which
are specialized dendritic cells of the immune system (C and JS 2007). Langerhans cells are also
found in the dermis, lymph nodes and thymus (C and JS 2007). The red bone marrow produces
Langerhans cells, then these cells move up to the stratum spinosum layer (F and R 2002).
Langerhans cells attract and phagocytose microbes then present their antigens to T lymphocytes
and activate lymphocytes to attack the microorganisms (F and R 2002).

2.1.2. Stratum Granulosum Layer
As keratinocytes move up to the stratum granulosum layer, they become longer and
flatten horizontally (GJ and BH 2009). The stratum granulosum layer is three to five layers of
7

flattened keratinocytes thick (GJ and BH 2009). This layer consists of dead keratinocytes,
proteins keratohyalin, and Odland’s bodies (F and R 2002). When reach this layer, keratinocytes
often go through apoptosis, a programmed cell death, in which the nucleus breaks up and the
cells die (GJ and BH 2009). After that, the cells become keratinised and mainly compose of a
tough protein called keratin (F and R 2002). The stratum granulosum also contains keratohyalin,
a protein that can convert tonofilaments into keratin (GJ and BH 2009). Odland’s bodies are also
found in this layer (GJ and BH 2009). These are lamellar granules that produce lipid and help
connect individual keratinocyte together (GJ and BH 2009).

2.1.3. Stratum Lucidum Layer
The stratum lucidum layer is only found in thick skin areas such as the palms of the
hands and soles of the feet (GJ and BH 2009). The statum lucidum often consists of three to five
layers of clear, dead, and flattened keratinocytes with thick plasma membranes (GJ and BH
2009).

2.1.4. Stratum Corneum Layer
The stratum corneum is the top skin layer and consists of 25-30 layers of dead and
flattened keratinocytes (GJ and BH 2009). These keratinocyte cells contain protein keratin that
can protect underlying skin layers from heat, microorganisms and chemicals (GJ and BH 2009).
The intracellular lipid from the lamellar granules in the stratum granulosum plays an important
role in keeping the cells together and preventing the cells from drying out (GJ and BH 2009). As
keratinocyte cells move through the stratum corneum, they start to dissociate from each other
and are shed singly or in clumps (GJ and BH 2009). Since keratinocyte cells in the stratum
corneum are exposed to external environment, they are lost on a continuous basic and are
8

replaced with new cells moving up from the stratum basale, the deepest skin layer (GJ and BH
2009). A hard callus, an abnormal thickening of the stratum corneum, is usually formed when an
area of the skin is constantly exposed to friction (GJ and BH 2009).

2.1.5. Dermis
The dermis is below the epidermis and above the subcutaneous layer. It provides
nutrients and serves as a physical support to the epidermis (F and R 2002). The dermis contains
lymph vessels, nerve endings, hair follicles and different glands. The dermis is connected to the
epidermis via rete ridges (F and R 2002). These rete ridges allow the exchange of nutrients
between the dermis and epidermis (F and R 2002). If for some reasons, the dermis and epidermis
layers become separated as a result of shearing force, fluid will accumulate between two layers
and form blister (C and JS 2007).
The dermis contains two layers: the reticular and papillary layers (F and R 2002). The
papillary layer contains nerves and capillaries that supply nutrients to the whole dermis (F and R
2002). The reticular layer contains strong connective tissue made up of elastin and collagen
fibers (F and R 2002).
Collagen and Elastin Fibers
Collagen proteins in connective tissue fibers account for 70% of the dry weight of the
dermis (F and R 2002). With a high tensile strength, collagen fibers prevent tearing when the
skin is stretched (F and R 2002).
Elastin fibers are found interwoven among collagen fibers (GJ and BH 2009). With
elastic properties, elastin fibers allow the skin to return to its normal position after stretching (GJ

9

and BH 2009). As people age, the number of elastin fibers reduces, elastin fibers start to lose
their elasticity, thicken into bundles and result in wrinkled appearance skin (GJ and BH 2009).
Eccrine Glands
Eccrine glands are simple, coiled glands that are mostly distributed in the skin of the
forehead, palms of the hands and soles of the feet (GJ and BH 2009). Sweat from the eccrine
glands is composed of water, sodium, chlorine ions, urea, uric acid, ammonia, amino acids,
glucose and lactic acid (GJ and BH 2009). There is an average of 600 mL of sweat produced by
the eccrine glands daily (GJ and BH 2009).
Apocrine Glands
Apocrine glands are activated by sex hormones during puberty (F and R 2002). The
apocrine glands are coiled, tubular glands and are mainly distributed in the axillae, groin, areolae
of the breasts and bearded regions of the face in adult male (GJ and BH 2009). The apocrine
glands produce milky, yellowish sweat (GJ and BH 2009). This sweat has no smell but when it
meets with the bacteria on the surface of the skin, the bacteria break down components of the
sweat and produce body odor (GJ and BH 2009).
Sebaceous Glands
A sebaceous gland has a sac-like secretory unit and an obvious lumen. Most sebaceous
glands are connected to hair follicles (F and R 2002). Sebaceous glands produce sebum, an oily
substance composed of triglycerides, cholesterol, proteins and organic salts (F and R 2002).
Sebum protects hair surface from becoming drying and brittle (F and R 2002). Sebum also has
antifungal and antibacterial properties (F and R 2002).
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Ceruminous Glands
Ceruminous glands are found in the external ears (GJ and BH 2009). Ceruminous glands
produce waxy secretion that can combine with secreted substance from the sebaceous glands to
form a yellowish substance called cerumen (GJ and BH 2009). Cerumen and the hair in the
external auditory canal prevent the entrance of foreign bodies and insects into the ear (GJ and
BH 2009).
Blood Vessels
There are two main blood networks: the deep plexus and the superficial plexus (F and R
2002). The deep plexus is found at the boundary of the dermis and the subcutaneous fat layer (F
and R 2002). This network supplies blood for tissues in the dermis and subcutaneous layer. The
superficial plexus is found at the uppermost layer of the dermis and provides blood for the
dermis and epidermis tissues (F and R 2002).
Hair
Each hair is made up of dead, keratinized epidermal cells connected together with
extracellular proteins (GJ and BH 2009). The shaft of hair is the part that grows above the
surface of the skin, the root of the hair is the segment that is below the skin surface and anchored
to the dermis or subcutaneous layer (GJ and BH 2009). The root of the hair is surrounded by a
hair follicle (GJ and BH 2009). The dermis that encircles the hair follicle is called the dermal
root sheath (GJ and BH 2009). The base of each hair follicle and its dermal root sheath is
collectively called the bulb (GJ and BH 2009). The bulb contains hair matrix cells, which come
from the stratum basale layer where cell division occurs (GJ and BH 2009). Hair matrix cells
contribute to the growth of existing hairs (GJ and BH 2009).
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Each hair follicle normally goes through three stages of the growth cycle: growth,
regression and resting (GJ and BH 2009). The cells of the hair matrix divide during the growth
stage and new cells are added at the base of the hair follicle (GJ and BH 2009). In the growth
stage, as hair gets longer, it becomes keratinised and dies (GJ and BH 2009). Hair remains in the
growth stage for two to six years (GJ and BH 2009). In the regression stage, the hair stops
dividing and remains in this stage for two to three weeks (GJ and BH 2009). Then the hair enters
resting stage and remains in this phase for about three months (GJ and BH 2009). On average, an
adult loses about 70-100 hairs per day (GJ and BH 2009).

2.2. Functions of the Skin
The skin has four main functions: sensation, thermoregulation, protection and synthesis
of vitamin D (E, A et al. 2009). Since the skin has about one million nerve fibers, it is able to
sense cold, heat, pain, touch and pressure (E, A et al. 2009). The skin also contains many
receptors that can sense temperature and transmit impulses back to the hypothalamus in the
forebrain (E, A et al. 2009). The hypothalamus then sends signals back to receptors in the skin to
regulate temperature (E, A et al. 2009). The skin has many thermoregulatory mechanisms such
as insulation, sweating and control of blood flow (E, A et al. 2009). Moreover, the skin also
serves as the body’s physical barrier and prevents harmful microorganisms to colonize and enter
the body (F and R 2002). It also prevents fluid loss and protects the internal organs from drying
out (F and R 2002). In addition, the skin also synthesizes Vitamin D from cholesterol when the
skin is exposed to UV light from the sun (GJ and BH 2009). Vitamin D plays a critical role in
controlling the amount of calcium and phosphorus that the body absorbs via the small intestine
and bone (GJ and BH 2009). Calcium and phosphorus are important in bone formation (GJ and
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BH 2009). Vitamin D deficiency can lead to bone softening diseases known as rickets in children
and osteomalacia in adults (GJ and BH 2009).

2.3. Skin Cancer
Skin cancer is the uncontrolled growth of abnormal skin cells. Skin cancer is mostly
caused by exposure to ultraviolet radiation (UV) from the sun or tanning beds. UV radiation
causes DNA damage in skin cells and triggers mutations or genetic defects that eventually lead
skin cells to multiply rapidly, out of control and form malignant tumors.
Most skin cancer cases are caused by UV radiation from sunshine (Vladislava O.
Melnikova 2004). The sun emits three types of UV light: UVA (320-400 nm), UVB (280-320
nm), and UVC (200-280 nm) (Vladislava O. Melnikova 2004). However, the UVC is blocked
by the ozone layer and cannot reach the earth’s surface. Therefore, only UVA and UVB can
penetrate our skin and cause harm. With a short wavelength 280-320 nm, UVB can only
penetrates the epidermis, the most superficial layer of our skin, and increase the risks of skin
cancer (Vladislava O. Melnikova 2004). With a longer wavelength 320-400 nm, UVA can
penetrate deeper into the skin and cause aging, and wrinkling of skin (Vladislava O. Melnikova
2004).
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Figure 2.1: UVA and UVB Wavelengths Can Penetrate Skin and Cause Damage
(Administration 2014)

Skin cancer is usually classified into 3 different types: basal cell carcinoma, squamous
cell carcinoma, and melanoma. They are different because they arise from 3 different types of
cells that found in the epidermis, the outermost layer of skin (Foundation 2013).

Figure 2.2: A Cut-away View of Skin (Association 2013)
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The skin is made up of 3 layers: epidermis, dermis, and fat layer (Foundation 2013).
Epidermis is the outer layer of the skin (Foundation 2013). Dermis is the middle layer of the
skin. It contains nerves, blood vessels, sweat glands, hair follicles, and oil producing cells to
prevent the skin from drying out (Foundation 2013). The fat layer is the deepest layer of the skin
(Foundation 2013). It is mostly made up of fat cells (Foundation 2013).
Skin cancer usually begins in the epidermis (Foundation 2013). The epidermis is made up
of 3 different types of cell that give names to 3 different types of skin cancer (Foundation 2013).
Squamous cells are cells that form the outermost surface of the skin (Foundation 2013). These
cells contain keratin, which is a tough, insoluble protein that makes the skin waterproof
(Foundation 2013). Basal cells are cells at the base of the epidermis and serve as a reservoir for
squamous cells lost from the skin (Foundation 2013). Melanocytes are cells within the epidermis.
These cells produce pigment, a dark material that gives the skin its color (ehealthMD 2013,
Foundation 2013).

2.4. Three Types of Skin Cancer
About 80% of skin cancer cases are basal cell carcinoma, a cancer that develops in the
basal cells in the lowest layer of epidermis (Foundation 2013). Squamous cell carcinoma, a
cancer that begins in the squamous cells in the upper layer of epidermis, accounts for 16% of
skin cancer cases (Foundation 2013). About 4% of diagnosed skin cancers are melanoma
(Foundation 2013). Melanoma is a cancer that begins in melanocytes, cells within the epidermis
that give skin its color (Foundation 2013). Although melanoma is the rarest form of skin cancer,
it is the most lethal form because it can spread to lymph system and internal organs. Studies
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showed that in the US, on average, one person dies from melanoma every hour (Foundation
2013).

Figure 2.3: The Relevance of 3 Types of Skin Cancer

2.4.1. Basal Cell Carcinoma
Dermatologists examine the morphology of the skin to diagnose skin cancer. Basal cell
carcinoma is the most common form of skin cancer. There are more than 2.8 million cases of
BCC diagnosed in the US each year (Foundation 2013). Basal cell carcinoma (BCC) is caused by
the uncontrolled growth of the skin’s basal cells that located at the lowest layer of the skin
(Foundation 2013). BCCs often look like open sores, red patches, pink growths, shiny bumps, or
scars (Foundation 2013). BCCs usually do not spread beyond the original tumor site.
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Figure 2.4: Basal Cell Carcinomas Morphology (Foundation 2013)

2.4.2. Squamous Cell Carcinoma
Squamous cell carcinoma (SCC) is caused by the uncontrolled growth of some abnormal
squamous cells that make up the upper layer of the epidermis (Foundation 2013). SCCs look like
scaly red patches, open sores, or elevated growths with a central depression (Foundation 2013).
More than 700,000 new cases of SCC are diagnosed in the US each year and SCC also causes
2500 deaths annually (Foundation 2013).

Figure 2.5: Squamous Cell Carcinomas Morphology (Foundation 2013)

2.4.3. Melanoma
The most dangerous form of skin cancer is melanoma. Melanoma is caused when
unrepaired DNA damage to skin cells triggers mutations and causes cells to multiply rapidly and
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forms malignant tumors. These tumors often originate from melanocyte located at the bottom
layer of the skin’s epidermis (Foundation 2014). Melanocytes are cells that producing melanin,
the pigment responsible for skin color (Foundation 2014). Melanoma often appears in an existing
mole or a new mole that is changing shape and color (Foundation 2014). There are about
120,000 new cases of melanoma are diagnosed in the US each year (Foundation 2014).
Melanoma also causes 8790 deaths in the US annually (Foundation 2014).

Figure 2.6: Melanoma Morphology (Foundation 2014)

2.5. Five ABCDEs Warning Signs of Melanoma
A – Asymmetry
The mole appears to be asymmetrical.

Figure 2.7: The Assymetry Sign of Melanoma. Image Source: (Foundation 2014)
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B – Border
The borders of melanoma often look uneven.

Figure 2.8: The Border Sign of Melanoma. Image Source: (Foundation 2014)
C – Color
A melanoma usually has a variety of color or shades.

Figure 2.9: The Color Sign of Melanoma. Image Source: (Foundation 2014)
D – Diameter
Melanomas often are larger than the size of the eraser on your pencil (1/4 inch or 6 mm).

Figure 2.10: The Diameter Sign of Melanoma. (Foundation 2014)
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E – Evolving
Any changes in size, shaper, color of existing moles may be the signs of early melanoma.

Figure 2.11: The Evolving Sign of Melanoma. Image Source: (Foundation 2014)

2.6. Skin Cancer Diagnosis
If you notice any changes on your skin in color, size, shape of the moles or the
appearance of a tumor, you should see a dermatologist for a skin cancer screening. The
dermatologist can either exam or do a biopsy to remove a portion of the suspicious area and send
the tissue to a lab to be examined by a dermatopathologist. The lab results then show whether or
not you have skin cancer and the type of skin cancer that you have.

2.7. Treatments for Skin Cancer
There are different treatment options available for skin cancer including freezing,
scraping and burning, surgical removal, laser surgery and Mohs micrographic surgery.
Mohs Micrographic Surgery
Mohs micrographic surgery is accepted as the single most effective technique for
removing basal cell carcinoma and squamous cell carcinoma with 98% success cure rate
(Foundation 2014 ). Cancer cells can be present in the deeper tissues than the visible moles and
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can cause recurrence of skin cancer if these cancer cells are not completely removed (Foundation
2014 ). Mohs micrographic surgery was first described by Dr. Frederic Mohs in 1941
(Foundation 2014 ). This surgery involves surgeons remove skin tissue sequentially (layer by
layer) then examine under the microscope immediately until the tissues are clear of cancer cells
(Foundation 2014 ). Most patients usually clear of cancer cells after 2 or 3 layers of skin tissue
removal (Foundation 2014 ). On average, Mohs surgery usually takes from 2 to 7 hours
(Foundation 2014 ). The outline of Mohs surgery is shown as in Figure 2.12 (Foundation 2014 )
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Step 1
The roots of a skin cancer may extend beyond the visible portion
of the tumor. If these roots are not removed, the cancer will recur.

Step 2
The visible tumor is surgically removed.

Step 3
A layer of skin is removed and divided into sections. The surgeon
then color codes each of these sections with dyes and makes
reference marks on the skin to show the source of these sections.
A map of the surgical site is then drawn.

Step 4
The undersurface and edges of each section are microscopically
examined for evidence of remaining cancer.

Step 5
If cancer cells are found under the microscope, the surgeon marks
their location onto the "map" and returns to the patient to remove
another layer of skin - but only from precisely where the cancer
cells remain.
Step 6
The removal process stops when there is no longer any evidence of cancer remaining in the
surgical site. Because Mohs surgey removes only tissue containing cancer, it ensures that the
maximum amount of healthy tissue is kept intact.

Figure 2.12: The Outline of Mohs Micrographic Surgery. Image Source: (Surgery 2013)
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2.8. Skin Cancer Pathology
The transition process from a normal keratinocyte to a neoplastic cell is a very
complicated process that involves both genetic and epigenetic factors (Melnikova and
Ananthaswamy 2005). UV radiation causes DNA damage, inflammation, erythema, sunburn,
immunosuppression, photoaging, gene mutation and eventually skin cancer (Melnikova and
Ananthaswamy 2005). Upon exposure, UV radiation causes DNA damage and induces the over
expression of p53, a tumor suppressor protein in keratinocytes. P53 proteins will initiate
different cascade pathways to arrest the cell cycle, repair DNA, initiate the apoptosis process
and activate cell survival and proliferation (Melnikova and Ananthaswamy 2005). Moreover,
when keratinocytes are exposed to UV radiation chronically, the generation of DNA
photoproducts and defects in DNA repair will cause the accumulation of mutations in p53 tumor
suppressor gene, deregulation of Fas/FasL signaling and an increase in apoptosis resistance
(Melnikova and Ananthaswamy 2005). These events will eventually lead to the clonal
expansion of p53-mutated keratinocytes, activation of ras oncogenes and mutations in PATCH,
INK4a/ARF tumor suppressor genes (Melnikova and Ananthaswamy 2005). These cellular
events cause UV-induced skin tumors to eventually develop into squamous cell carcinomas
(Melnikova and Ananthaswamy 2005). The progression from normal keratinocytes to squamous
cell carcinoma is summarized in Figure 2.13 below.
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Figure 2.13: Progression of Human Squamous Cell Carcinoma (Melnikova and
Ananthaswamy 2005)

2.8.1. Cellular Changes after Exposing to Acute UV DNA Damage
DNA molecules are made up of polynucleotides. Each nucleotide contains a nitrogencontaining nucleobase – either Guanine (G), Adenine (A), Thymine (T) or Cytosine (C) as
shown in Figure 2.14. Adenine (A) pairs with Thymine (T) and Guanine (G) pairs with
Cytosine (C).

24

Figure 2.14: Structure of DNA Molecules
Pyrimidine bases include cytosine (C) and thymine (T). Upon exposure to UVB radiation,
it will induce cyclobutane-type pyrimidine dimmers and pyrimidine (6-4) pyrimidone
photoproducts in the DNA structure of skin cells (Brash 1988). The energy from UV light will
cause two adjacent pyrimidine bases (cytosine: C and thymine: T) to form covalent bonds and
result in pyrimidine dimmers (C-C, C-T, T-C, T-T) (Brash 1988). A pyrimidine dimmer for
example a thymine dimmer (T-T) will create a bend in DNA structure and stall the DNA/RNA
polymerase as shown in Figure 2.15.
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Figure 2.15: UVB Induces Pyrimidine Dimmers and Stops Movement of DNA/RNA
Polymerase (Block)
Skin cells have a DNA repair mechanism call Nucleotide Excision Repairs (NER) that
can remove these pyrimidine dimmers (DNA lesions) (Brash ED 1991). The NER mechanism
will remove a short single-stranded DNA segment that contains the pyrimidine dimmers and
uses the undamaged single stranded DNA remains as a template to synthesize a complementary
sequence to repair the DNA damage as shown in Figure 2.16 (Brash ED 1991).

26

Figure 2.16: Nucleotide Excision Repair (NER) Mechanism (StudyBlue 2014)
However, when skin cells are exposed to UVB radiation repetitively without adequate
time for DNA repair, it exceeds the capability of NER mechanisms to remove all pyrimidine
dimmers and repair DNA (Brash ED 1991). This leads to mutations C → T and CC → TT at
Pyrimidine Dimmers (Brash ED 1991). These mutations occur according to the A rule: when
DNA polymerase interacts with lesions in the DNA template that it cannot interpret, it inserts
Adenine (A) residues by default (Brash ED 1991) as shown in Figure 2.17. All the complement
bases of pyrimidine dimmers (CC, CT, TC, TT) are Adenine (A) if the NER mechanism fails to
repair the DNA lesions (Brash ED 1991). This leads to the mutation of C → T and CC → TT at
pyrimidine dimmers, which are recognized as the UV fingerprint mutations (Brash 1988).
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Figure 2.17: UVB induced Mutations C → T and CC → TT at Pyrimidine Dimmers (Rass
and Reichrath 2008)
UVB radiation induces pyrimidine dimmers and (6-4) photoproducts, which can lead to
UV fingerprint mutation C → T and CC → TT at pyrimidine dimmers (Brash ED 1991). These
mutations can affect genes that codes for important proteins or enzymes that control cell cycle,
DNA repair and apoptosis. After exposing to chronic UVB radiation for years, many more
mutations will accumulate in these critical genes and will trigger affected cells to grow out of
control and form malignant tumors (Brash ED 1991).
UVA radiation causes DNA damage indirectly by producing reactive oxygen species
such as superoxide anion, singlet oxygen and hydrogen peroxide (Boiteux 1993). These
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molecules induce other DNA lesions include cytosine photohydrates, purine photoproducts, sing
strand breaks in DNA, DNA-protein crosslinks, and altered bases in DNA (Boiteux 1993).
Inducing Expression of p53, a Tumor Suppressor Protein
DNA damage will trigger the cells to induce the expression of p53, a tumor suppressor
protein (A.J. Levine 1991). UV radiation causes phosphorylations of many serine residues on
p53 include Ser15, Ser20, Ser33, Ser37, Ser46 and Ser392 (J.D.Siliciano 1997, N.H. Chehab
1999, M.Kapoor 2000). The phosphorylation of Serine residues on p53 disrupts the interaction
of p53 and its negative regulator Mdm2, enhances the transcriptional activity of p53 and
promotes p53 to move from cytoplasm to nucleus (Melnikova and Ananthaswamy 2005).
Inducing Cell Cycle Arrest, DNA Damage Repair and Apoptosis
Once inside the nucleus, p53 will trigger many other pathways including cell cycle arrest
to repair DNA damage, DNA damage repair, inhibition of angiogenesis and metastasis, and
apoptosis as shown in Figure 2.18 (Vladislava O. Melnikova 2004).
P53 proteins cause cell cycle arrest at the G1 phase by activating the p21/WAF1/CIP1
pathway. P21 proteins bind to and inactivate the cyclinD/cdk4, cyclin D/cdk6 and cyclin E/cdk2
complexes which are important in the progression of cells from G1 to S phase. This event
causes the cells to be arrested in G1 phase to allow more time for DNA repair to occur (J.W.
Harper 1993).
P53 proteins also trigger DNA damage repair pathways such as nucleotide excision repair
(NER) and base excision repair (BER) (B.J. Hwang 1999, S.A. Amundson 2002). In NER, p53
activates proteins p48XPE, XPC and GADD45 (Vladislava O. Melnikova 2004). These proteins
bind to the damage DNA and initiate the process of repairing DNA (B.J. Hwang 1999, S.A.
Amundson 2002).
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Intensive DNA damage caused by UV radiation also triggers the expression of p53. P53
then induce the increase in expression of proapoptotic genes that cause mitochrome c release
from mitochondria. Cytochrome c then interacts with Apaf-1 proteins, recruits procaspase 9,
activates the apoptosomal complex and leads to apoptosis (T. Miyashita 1995).

Figure 2.18: p53 Initiates Different Cellular Pathways to response to UV-induced DNA
Damage (Melnikova and Ananthaswamy 2005)
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2.8.2. Cellular Changes after Exposing to Chronic UV
When skin cells are exposed to chronic UV radiation, it will promote cells to progress to
skin cancer more rapidly by inducing many irreversible cellular changes. First, it will cause
more mutations in p53 tumor suppressor gene (H. Nakazawa 1994). Research studies showed
that a high frequency of p53 mutations was found in premalignant actinic AK lesions, which are
precursors of squamous cell carcinoma. Ziegler et al. found that 66% of AK lesions had p53
mutations (A. Ziegler 1994). Second, chronic UV radiation also causes skin cells to be highly
resistant to apoptosis. Exposure to chronic UV radation changed the expression of Fas
receptors, (programmed cell death receptors) and affect their interaction with the Fas ligands (A.
Ouhtit 2000). This led to a decrease in apoptosis. Research studies showed that after 1 week of
continuous exposure to UV radiation, the transcription of Fas receptors were inhibited in mice
model. This resulted in a decrease in apoptotic cells (A. Ouhtit 2000). Third, clones of
keratinocytes carrying mutated p53 expanded after exposing to UVB radiation for a long time
(R.J.W. Berg 1996, W.Zhang 2001). These mutated keratinocytes can grow rapidly because
they are resistant to apoptosis and can proliferate faster than normal keratinocytes (V.A. Tron
1998, A.V. Mudgil 2003). Research studies showed that a single UV exposure could stimulate
the growth of mutated p53 keratinocytes but induce apoptosis in normal keratinocytes (V.A.
Tron 1998, A. V. Mudgil 2003). Finally, chronic UV exposure also caused mutations in the
patched gene (PTCH) and INK4a/ARF tumor suppressor genes (Y. Matsumura 2002).
Researchers found mutations in PTCH genes in basal cell carcinomas patients (Y. Matsumura
2002). Studies also showed that 76% of 40 human squamous cell carcinoma (SCC) had
alterations in the INK4a/ARF locus (V. L. Brown 2004). Although the exact mechanisms of
how normal keratinocytes developed into malignant tumors remain unknown, these cellular and
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molecular changes were found to contribute to the progression of UV-induced DNA damage
keratinocytes into skin cancer after chronic exposure to UV radiation.

2.9. Cell Cycle

Figure 2.19: Cell Cycle (Scicurious 2014)
The human body contains about 100 trillion cells. All these cells, except for the red blood
cells, undergo the cell cycle to divide and form new cells (Scicurious 2014). The cell cycle
process accounts for the development of a single cell fertilized egg into a mature organism, the
renewal of hair and skin cells and new cells of some internal organs. The cell cycle can be
divided into 4 phases: G1, S, G2, and M as shown in Figure 2.19. During the G1 (Gap 1) phase,
the cell grows in size and checks to ensure that its internal system is functioning normally
(Scicurious 2014). There is a check point at the end of G1 phase. The cell has to reach a certain
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size and any damages to its DNA structure has to be corrected before the cell can move on to S
phase. If something is wrong or the damages of DNA cannot be corrected, the cell will stop
progressing through the cell cycle and initiate apoptosis (programmed cell death). During the S
(Synthetic) phase, the cell replicates its DNA molecules. After that, the cell will enter the G2
(Gap 2) phase. During the G2 phase, the cell will continue to grow and check that everything
inside the cell is ready before the cell divides in the M phase. During the M (mitosis) phase, the
cell divides into 2 identical daughter cells. Each daughter cell then starts the cell cycle again to
form new cells and enters the G1 phase. Sometimes, cells will leave the cell cycle and enter a
phase called G0 (quiescent) temporarily or permanently. Usually, cells enter G0 phase when they
are not ready for cell division because they are too busy carrying out other functions such as
secreting or attacking pathogens (virus, bacteria, etc) (Science , 2012).

2.10. Protein p21 and Its Cellular Functions
2.10.1. Protein p21 Background
Protein p21, also known as Cip1 or Waf1, is a cyclin-dependent kinase inhibitor, was first
discovered in 1993 (El-Deiry, Tokino et al. 1993, Wade Harper, Adami et al. 1993). Protein
p21Cip1/Waf1 is coded by the gene CDKN1A, it contains 164 amino acids and has a molecular
weight of 20 KDa. The p21Cip1/Waf1 was identified as the first inhibitor of cyclin-dependent
kinases (CDKs). This protein can inhibit cyclin-dependent kinases CDK2, CDK3, CDK4 and
CDK6, which are proteins that play important roles in the progression of cell cycle. Since p21
protein was able to bind and interact with CDKs, it was named CIP1, which abbreviated for
CDK interacting protein 1. Moreover, p21 protein was also known as the product of a gene
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activated by wild-type p53. Therefore, p21 was named WAF1, which stood for wild-type p53
activated factor (Gartel and Tyner 1999).

2.10.2. Protein p21 Cellular Functions
p21Cip1/Waf1 protein can be found in both nucleus and cytoplasm. Depending on the
localization, p21Cip1/Waf1 protein participates in important cellular pathways and plays an
important role in 5 different cellular biological processes: cell cycle, DNA replication/repair,
gene transcription, apoptosis and cell motility (Jana Cmielova 2011).
When the cell is exposed to genotoxic stress such as ionizing radiation, UV radiation,
chemical mutagens and cytostatics, it can lead to DNA damages in the nucleus. Cells try to
repair the DNA damage as soon as possible to preserve its genomic stability and prevent the
mutated DNA to be passed on to daughter cells (Cazzalini, Scovassi et al. 2010). Under normal
physiological conditions, p53 proteins are mostly present in the cytoplasm. However, shortly
after DNA damage, p53 protein is accumulated in the nucleus. In the nucleus, p53 acts as a
transcriptional factor and induces the expression of p21 proteins (Solozobova, Rolletschek et al.
2009). Protein p21 then stops the cell cycle at the G1/S checkpoint by interacting with CDK2
proteins so that cell has time to repair DNA. P21 also interacts with PCNA proteins to prevent
replication of the damaged DNA. Cells that lack p21 proteins or were mutated and lost the
ability to induce expression of p21 will continue with DNA synthesis and end up with abnormal
or damaged DNA in its daughter cells (Garner and Raj 2008).
The G1/S checkpoint is a mechanism cell uses to prevent the replication of damaged
DNA. Under normal conditions, at the end of the G1 phase, the CDK2/Cycline E complex is
responsible for the complete phosphorylation of Rb proteins (Retionoblastoma proteins). The
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fully phosphorylated Rb proteins release the E2F factors that will induce the expression of S
phase genes. This will lead the cell through the G1/S checkpoint (Satyanarayana A 2008).
However, when human skin cells are exposed to sunlight, UV radiation can cause DNA damage
in human skin cells, DNA damage then leads to the accumulated expression of p53 proteins in
the nucleus, the p53 proteins then induce the expression of p21 proteins. P21 proteins can
inhibit the activity of CDK2, so the CDK2/Cyclin complex can’t phosphorylate Rb proteins.
This leads to an accumulation of hypophosphorylated Rb proteins (Garner E 2008). The
hyposphosrylated Rb proteins do not release E2F factors, which in turn inhibit the expression of
S phase genes and stop the cell cycle at the G1/S checkpoint. This is the mechanism of how p21
proteins arrest the cell cycle at the G1/S checkpoint to prevent cell from replicating the DNA
damage (Ju Z 2006).
Protein p21 also interacts with PCNA proteins and involves in another mechanism to
prevent the replication of the damaged DNA from occurring. Under normal conditions, at the
end of G1 phase, the expression level of PCNA proteins increase and PCNA move from the
cytoplasm into the nucleus. PCNA is a cofactor of DNA polymerase, which involves in DNA
replication (Lee, Kim et al. 2009). After DNA damage occurs, p21 proteins expression increases
in the nucleus. These p21 proteins can react to a part of PCNA and inhibit PCNA to bind to
DNA polymerase. Without the cofactor PCNA, DNA polymerase can’t replicate and make
another copy of the damaged DNA (Li, Xie et al. 2006) (Prives and Gottifredi 2008). This is a
mechanism of how p21 proteins prevent cells from synthesizing another copy of the damaged
DNA molecules.
Moreover, p21 proteins can prevent the replication of the damaged DNA by binding to
transcriptional factors such as NF-KB, Myc, STAT3, and estrogen receptors or by regulating the
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activity of transcriptional co-factors such as p300/CBP (Dotto 2000, Perkins 2002, Coqueret
2003).

2.11. Milk Phospholipids

Figure 2.20: The Structure and Composition of Milk Fat Globule Membrane. Source:
(Robenek, Hofnagel et al. 2006)
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Figure 2.21: Structure of the Milk Fat Globule Membrane. Source: (Christelle Lopez 2010)
Milk is the most important food source for all mammal newborns. Most nutritional values
of milk reside in small droplets (mean diameter 4 µm) called milk fat globules (Keenan 2001,
Heid and Keenan 2005). The structure of the milk fat globule is shown in Figure 2.20 above.
Milk fat globule is secreted by the epithelial cells of the mammary glands. Milk fat globule
contains triacylglycerols, an important source of energy at its core and biological active
molecules such as polar lipids and glycoproteins at its membrane (Spitsberg 2005). Research
studies also found that the components of the milk fat globule membrane (MFGM) are involved
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in anti-infection or anti-adhesion which ultimately protects the newborns from bacterial and
viral infection.
The MFGM has been studied extensively because it contains many important
phospholipids that have beneficial health effects such as regulation of the inflammatory
reactions, protective effects against gastrointestinal infections and colon cancer, and reducing
cardiovascular risk factors (Kullenberg 2012).
The MFGM consists of 3 phospholipid membrane monolayers. The milk fat globules are
formed by the accumulation of the milk lipids in the endoplasmic reticulum (ER), the milk
lipids then bud off the ER in the form of small vesicles (Mather and Keenan 1998).Therefore,
the innermost layer of the milk fat globules membrane is the monolayer of phospholipid layer
from the cytoplasmic leaflet of the ER membrane (Patton and Keenan 1975). These small
vesicles containing lipids are then secreted outside of the cells (Murphy 2001). As a result, the
outermost layer of the milk fat globule membrane is the membrane bilayer consisting of the
extracellular and cytoplasmic leaflets of the plasma membrane.
Most of the milk fat globule membrane and its phospholipids come from the apical
plasma membrane of the mammary gland secretory cell. The components of the milk fat globule
membrane are shown in Figure 2.21. About 60% - 70% of milk phospholipids are present in the
external bilayer membrane of the milk fat globule membrane. These phospholipids are
organized as a liquid-disordered phase coexisting with a liquid-ordered phase, called the lipid
raft, which is rich in sphingomyelin and cholesterol (Gallier, Gragson et al. 2010, Lopez 2010).
Glycerophospholipids and sphingolipids, constitute 0.5% - 1% of milk fat, are the most
important milk phospholipids because they have many positive health benefits (Gallier, Gragson
et al. 2010, Lopez 2010).
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The MFGM is composed of glycoproteins (20-60%), glycerophospholipids (15-33%),
sphingolipids, glycolipids, triacyclyerols, sterols (0.3%), enzymes and other minor components
(Keenan T.W 1995). The most important glycerolphospholipids of the MFGM are
phophatidylcholine PC (35-36%), phosphatidylelethanolamine PE (27-30%),
phosphatidylinositol PI (5-11%), and phosphatidylserine PS (3-4%). The molecular structures of
these phospholipids are shown in Figure 2.22.

Figure 2.22: The Molecular Structures of Important Glycerophospholipids in the Milk Fat
Globule Membrane. Source: (Contarini and Povolo 2013)
Sphingolipids contain a long chain base, called the sphingoid base (sphingosine or
phytosphingosine), fatty acids and sugars or phosphoric acid or alcohols (Beare-Rogers,
Dieffenbacher et al. 2001). Sphingosine is the main sphingoid base in the mammalian
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sphingolipids. When a sphingosine links to a saturated fatty aid chain, it forms a ceramide.
Moreover, when a ceramide links to a phosphorylcholine head group, it forms a sphingomyelin
as in Figure 2.23 below. The major sphingolipid of the MFGM is sphingomyelin SM (25% of
total polar lipids) (Christie 1995, Lopez, Briard-Bion et al. 2008). The MFGM also contains
many glycoproteins such as the butyrophillin (20-40% of the total MFGM proteins), and heavily
glycosylated mucin-like glycoproteins MUC1 and MUC15, PAS6/7 and CD36 (Keenan T.W
2006).

Figure 2.23: The Molecular Structures of Sphingomyelin and Its Components.
Source: (Contarini and Povolo 2013)

2.12. Health Benefits of Bovine Milk Phospholipids
2.12.1. Reduced Risks of Type 2 Diabetes and Heart Disease
Pereira et al., 2002 investigated the association between dairy intake (consumption of
milk and dairy products) and the ten-year cumulative incidence of insulin resistance syndrome
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(IRS) over 3157 adults aged 18-30. They found that an increased consumption of dairy intake is
associated with a reduced incidence of obesity, glucose intolerance, hypertension and
dyslipidemia, which are components of IRS. The results from this study suggested that an
increased in dairy intake can lower the incidence of IRS, which in turn lower the risk factors of
type 2 diabetes and heart disease (Pereira Ma 2002).

2.12.2. Protective Effects against Gastrointestinal Infections and Febrile Episodes
Veereman-Wauters et al. 2012 found that consuming milk that was enrich with milk fat
globule membrane (0.25 g in 100 mL of milk) had health beneficial effects for young children
and significantly reduced the number of short febrile episodes (Veereman-Wauters, Staelens et
al. 2012).
Moreover, research studies also found that sphingolipids has protective effects against
gastrointestinal infections in vitro. They found that 100 mmol/L of lysophingomyelin was very
bactericidal against Campylobacter jejuni, Listeria monocitogenes and Clostridium perfringens,
and also decrease the viable counts of E.coli and Salmonella enteritidis (Sprong, Hulstein et al.
2001, Sprong, Hulstein et al. 2002).

2.12.3. Protective Effects against Chronic Stress and Improving Working Memory
One research group did a study on the effect of consuming bovine milk drink that was
enriched with phospholipids on 75 chronically stressed men aged 30 to 50. They found that
subjects that received milk with 0.5% phospholipids had a stronger increase of cortisol after
awakening and they also had a better memory performance than subjects in the control group
(Schubert, Contreras et al. 2011). These results suggested that bovine milk phsopholipids have
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protective effects against chronic stress and can help improve working memory in individuals
suffering from chronic stress.

2.12.4. Suppression of Colon Tumors
Recent research studies showed that sphingolipids are promising chemopreventive or
chemotherapeutic agents for colon cancer because they regulate cell growth, cell differentiation
and cell death. They are parts of the daily diet and a high dose of sphingomyelin is not harmful
to rodents. Moreover, many in vitro studies also demonstrated the involvement of sphingolipid
metabolites in cancer treatment. Increasing the ceramide and or sphingosine content in cells
either via hydrolysis of complex sphingolipids or de novo synthesis can induce cell apoptosis (a
programmed cell death) (Duan 2009).
Lemonnier et. al research study in 2002 found that sphingomyelin can suppress colon
tumors in mice model (Lemonnier L 2002). Throughout the intestinal tract, sphingolipids from
the diet are hydrolyzed to ceramide and free sphingoid bases. Intestinal cells then rapidly uptake
these metabolites. Ceramides and sphingoid bases regulate cell growth, differentiation, and
death. The intracellular targets of these metabolites are important enzymes that involved in
transformation and unrestricted cell growth such as members of the phosphatidilinositol-3
kinase and mitogen-activated protein kinase signaling pathway. Previous studies have shown
that non-pharmacological amounts in the diet can inhibit early stages of chemically induced
colon cancer in mice model. In Lemonnier et.al 2002 study, researchers investigated the
chemopreventive and chemotherapeutic effects of sphingomyelin supplements by feeding mice
0.05% sphingomyelin before and after tumor initiation. The average daily intake of
sphingolipids is about 0.3 – 0.4 g/day (0.01 – 0.02% of the diet by weight) (Vesper H 1999).
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Therefore, the amount of sphingomyelin in the mouse diet in this study can also be achieved in
human diet. In the sphingomyelin early (SM-E) group, 50 mice were fed a diet that was
supplemented with 0.05% sphingomyelin right after arrival. Colon cells have a life span of 3-5
days, so all cells were exposed to sphingomyelin before tumor initiation. One week after arrival,
the mice were injected with 1,2-dimethylhydrazine (DMH) (30 mg/kg body weight) once per
week for 6 weeks to trigger colon tumor formation. In the untreated control (UT) group, 14
mice were not injected with the carcinogen DMH and were fed the AIN 76A diet without
supplements during the entire research study. In the sphingomyelin late (SM-L) group, 50 mice
were on the AIN 76A diet during 6 weeks of tumor initiation, then received diet supplemented
with 0.05% sphingomyelin one week after the last carcinogen injection. In the control group, 60
mice were on the AIN 76A diet without sphingomyelin supplements during the entire study
(Lemonnier L 2002).
At forty five weeks after the last carcinogen injection, the animals were killed and their
colons were opened longitudinally. The number, location and size of tumors were noted. They
found that the tumor incidence in the control group was 23.3% (14/6), in the sphingomyelinearly (SM-E) was 6% (3/50) and in the sphingomyelin-late (SM-L) was 4% (2/50). Half of the
tumors in these groups were adenomas and the other half were carcinomas. The difference in the
tumor number and tumor incidence between the SM-E and SM-L groups was not statistically
significant. This suggested that sphingomyelin is potent in suppressing colon tumors when
administering before and after tumor initiation (Lemonnier L 2002).
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2.13. Western Blot
Western blot also known as immunoblot or protein blot is a core technique in the cell and
molecular biology research field and in medical diagnostics. Many commercial western blot kits
are available and used to diagnose HIV, Hepatitis B, and lyme diseases. In principle, western
blot is an antibody detection technique used to detect and quantify the expression of a specific
protein in a complex mixture of proteins extracted from cells. Western blot procedure often
involves four main steps. First, proteins are extracted from cells. Second, proteins are separated
from each other based on their sizes on a gel and then proteins are transferred to a membrane.
Third, primary and secondary antibodies are added to the membrane to detect the protein of
interest. The secondary antibodies are often conjugated with an enzyme such as alkaline
phosphatase or horadish perosidase. Finally, a substrate is added, the enzyme that was
conjugated with the secondary antibody will react with the substrate and produce signals as blue
or violet bands on the membrane. The intensities of the blue or violet bands on the membrane
correspond to the expression level of the target protein (KOMABIOTECH 2014).

2.13.1. Protein Extraction from Cells
First, proteins are extracted from cells using lysis buffer. The lysis buffer will break open the
cell’s membrane so that proteins can be released. Then, the tube containing the sample will be
centrifuged. After centrifugation, the proteins will be present in the supernatant in the top and
cellular debris will be present in the pellet at the bottom. The supernatant will be removed and
kept in a new tube as shown in Figure 2.24 below (NOVUSBIO 2014) .
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Figure 2.24: Protein Extraction Process (NOVUSBIO 2014)

2.13.2. Proteins are separated by sizes using SDS-PAGE gel electrophoresis
As shown in Figure 2.25 below, before protein samples are loaded on a gel, loading buffer is
usually added to the samples. Loading buffer contains SDS (Sodium Dodecyl Sulfate). The
samples are then heated to a near-boiling temperature, which denatures the proteins from a
globular structure to a linear structure and allows the SDS to bind to the proteins. Since the SDS
that binding to the proteins carries negative charges, the proteins become negatively charged
(NOVUSBIO 2014).
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Figure 2.25: Proteins Denaturation Process by SDS and Heat Treatment (NOVUSBIO
2014)
After this, different protein samples are loaded into different wells of a gel as shown in Figure
2.26. A ladder contains molecular weight markers are usually loaded onto the first well. The
ladder contains protein mixtures of known molecular weights, this allows researchers to
determine the molecular weight of other proteins on the gel. After the ladder and all the protein
samples are loaded, a current is run across the gel with the positive pole at the bottom of the gel.
Since the proteins bind to the negatively charged SDS, the proteins will be pulled down through
the gel to the positive pole. The larger the protein, the slower it will move. Therefore, the large
proteins will be at the top and all the small proteins will be at the bottom of the gel (BioRad
2014).
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Figure 2.26: Proteins are Separated by Sizes Using SDS-PAGE Gel Electrophoresis
(BioRad 2014)
As shown in Figure 2.27, after the gel is run, it is placed against a membrane and a current is
passed across the gel to the membrane to transfer the proteins from the gel to the membrane.

2.13.3. Primary and Secondary Antibodies are Added to the Membrane
Since antibodies are also proteins, they can bind non-specifically to the membrane. Therefore,
before adding antibodies, a non-specific protein such as BSA (bovine serum albumin) is added
to block empty spaces on the membrane. BSA will bind to the surface of the membrane where
proteins are not already present. This will prevent antibodies from binding to the surface of the
membrane and giving non-specific signals. After this, the primary antibody will be added to the
membrane. The primary antibody will only bind to the protein of interest. Then, the secondary
antibody is added to the membrane. The secondary antibody will bind to the primary antibody
(KOMABIOTECH 2014).
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2.13.4. A Substrate is Added and Produce Signals on the Membrane
Finally, a substrate is added. The enzyme on the secondary antibody will react with the
substrate and give either a blue or violet color. The blue or violet bands on the membrane
correspond to the proteins of interests.
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Figure 2.27: The Process of Detecting the Target Proteins on the Membrane
(KOMABIOTECH 2014)
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Chapter 3: Technical Challenges and Solutions
3.1. First Challenge - Developing a Protocol to induce p21 Expression in
Keratinocytes Using UV Light
Preliminary research studies showed that it was very crucial to expose keratinocytes to
the right dose of UV light to induce cells to express p21 proteins. If keratinocytes cells were
treated with a high UV dose, it would cause severe DNA damage in cells and trigger cells’
apoptosis (programmed cell death). On the other hand, if keratinocytes cells were exposed to a
low UV dose, only a small amount of cells would be affected and express p21 proteins to stop
the cells’ cycles to repair DNA damage. As a result, p21 proteins may be too little to be detected
by immunofluorescent or by western blot methods. To solve this technical challenge,
keratinocytes were exposed to different UV dosages including 30 mJ/cm2, 20 mJ/cm2 and 10
mJ/cm2. It was found that when exposing cells to a UV dosage of 10 mJ/cm2, cells expressed
very clear p21 signals and many cells were expressing p21 proteins when examining under the
confocal microscopes using the immunofluorescent method.
The following method was used to induce p21 expression in keratinocytes by exposing
them to UV light in the lab. Before UV radiation, keratinocytes were grown until they reach
about 80 – 90 % confluence in the 6-wells plates in the 370C incubator. First, all the light in the
room was turned off. Then, the UV light apparatus was turned on for at least 10 minutes before
radiation to ensure that the UV light was emitting a stable and constant dose rate. A UV light
probe was placed right under the UV light to measure the emitting power in the unit of mJ/s.
The obtained average emitting power is used to calculate the time needed to expose cells at a
UV dose of 10 mJ/cm2.
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The exposure time is calculated using the following formula:
Exposure time (seconds) = (Desired Dose) x (Area of Detector) / (Average Wattage)
= (mJ/cm2) x (cm2) / (mJ/s)
Before UV radiation, all the cell growth media was removed from the cell plates.
Keratinocytes in the plates were then washed with sterile PBS buffer for 2 times and the PBS
was removed completely from the plates. Then, the cell plates were placed directly under the
UV light for a specific calculated exposure time. When the appropriate time was reached, the
UV light was turned off and the cell plates were immediately removed from the UV light
apparatus. Then, a new pre-warmed cell growth media (370C) was added to the cell plates. The
new cell growth media is as the same amount as the old cell media. The cell plates were then
incubated in a 370C incubator for another 24 hours before cells were lysed to extract proteins.

3.2. Second Challenge - Determining Minimum Amount of Keratinocytes Needed
for Each Treatment
The second challenge was to determine the minimum amount of keratinocytes needed for
each treatment sample. It is very expensive in terms of materials cost and labor time to grow
keratinocytes in the lab. Therefore, it would be very efficient to know the minimum amount of
keratinocytes needed for each treatment sample to ensure that there would be sufficient proteins
and p21 proteins transferred to the PVDF membrane downstream. Preliminary research studies
were conducted to determine the minimum amount of cells needed. Cells from 2 wells (1/3
plate), 6 wells (1 plate) and 12 wells (2 plates) were used for 1 sample treatment. The results
showed that cells from 6 wells (1 plate) would yield sufficient proteins and p21 proteins to be
detected on the PVDF membrane as part of the Western blot essay. Cells from 6 wells (1 plate)
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yielded an average total protein concentration of 13086 µg/mL and cells from 2 wells (1/3 plate)
yielded an average total protein concentration of 2703 µg/mL. Experiment results also showed
that the amount of p21 proteins extracted from 6 wells (1 plate) was sufficient enough to be
detected on the PVDF membrane. The amount of p21 proteins extracted from 2 wells (1/3 plate)
was not sufficient enough to be detected. The results were illustrated on the PVDF membrane in
Figure 3.4 below. In batch 1, cells from 6 wells (1 plate) were used for each sample treatment
and in batch 2, cells from 2 wells (1 plate) were used for each sample treatment. In batch 1, 131
µg of proteins from each sample were loaded into each lane (lanes 3-6). In batch 2, 54 µg of
proteins from each sample were loaded into each lane (lanes 7-10) as in Figure 3.4 below. P21
proteins signals from batch 1 were detected very clearly in lanes 3 – 6. However, p21 proteins
signals from batch 2 were not detected in lanes 7-10. These results showed that if cells from 6
wells (1 plate) were used as 1 sample treatment, there would be sufficient p21 proteins and clear
p21 signals would be detected on the PVDF membrane.

3.3. Third Challenge - Developing a Working Western Blot Protocol to Show
p21 Signals
Finally, the third challenge was to develop a working Western Blot protocol to show
clear signals of p21 from each treatment on the PVDF membrane so that researchers can evaluate
the effects of milk phospholipids in protecting skin cells from UV induced DNA damage. Three
different experiment parameters that can be optimized in the Western blot assay include:
transferring time for proteins to move from SDS-PAGE gel to PVDF membrane, primary and
secondary antibody concentrations, and developing time for signals to appear clearly with a
minimized background noise on the PVDF membrane.
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3.3.1. First Experiment Parameter: Transferring Time
Transferring time parameter needs to be optimized because too long or too short
transferring time will affect whether or not the p21 signals are detectable on the PVDF
membrane. In the Western blot assay, after cells were exposed to UV light and incubated in the
370C incubator for 24 hours, proteins would be extracted by using lysis buffer to open up the
cells. Protein concentration from each treatment sample would be measured using BCA assay
and the same amount of proteins would be loaded into each lane of the SDS-PAGE gel. Proteins
would be separated based on their molecular weight by running gel electrophoresis. The smaller
proteins would travel farther down the gel faster than the bigger proteins. Since the interested
p21 proteins are buried among the agarose molecules of the gel, it is hard to use antibodies to
bind to and detect p21 proteins. Therefore, after gel electrophoresis, proteins are transferred from
an SDS-PAGE gel to a PVDF membrane using the Invitrogen iBlot Dry Blotting System as
shown in the Figure 3.1 below.

Figure 3.1: The Transferring Process of Proteins from Gel to PVDF Membrane Using
Invitrogen iBlot Dry Blotting System
The transferring time is very critical. If the transferring time is too short, not all p21
proteins would be able to move from the gel to the PVDF membrane and may result in no
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signals or faint signals of p21 detected on the membrane later. If the transferring time is too
long, p21 proteins may run over through the pores of PVDF membrane and results in no signals
or faint signals of p21 on the membrane. Preliminary experiments were performed to determine
the optimal transferring time. Molecular weight proteins and proteins from UV treated samples
were loaded in every 2 lanes of the gel. After gel electrophoresis, a cut was made at every 2
lanes of the gel and the proteins were transferred from the gel strips containing 2 lanes to the
PVDF membrane. Different transferring time periods were tested for each gel strip of 2 lanes
include 2, 3, 3.5, 4, 4.5, 5, and 5.5 minutes. Proteins were transferred from gel to membrane but
they are not visible on the membrane. Therefore, after the transferring process, the PVDF
membrane was stained in coomassive blue dye and washed in destaining solution. The
coomassive blue dye would bind to proteins and form a protein-dye complex. The protein-dye
complexes give a blue color and the proteins are therefore visible on the membrane. The results
were shown in Figures 3.2 and 3.3 below.

54

25 KDa
20 KDa

Figure 3.2: Proteins were transferred from Gel to PVDF Membrane in 2, 3, 4 and 5
Minutes
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25 KDa
20 KDa

Figure 3.3: Proteins were Transferred from Gel to PVDF Membrane in 3.5, 4, 4.5, 5, and
5.5 Minutes
Proteins p21 were expected to appear between the 20 and 25 KDa markers. Based on the
PVDF membranes in Figures 3.2 and 3.3 above, the transferring times 3.5 minutes and 4.5
minutes gave very strong proteins bands between the 20 and 25 KDa markers. Therefore, these
2 transferring times were chosen to test for the detection of p21 proteins using p21 antibody
proteins. The results were shown in Figures 3.4 and 3.5 below. Figure 3.4 showed the proteins
bands on the membrane after the membrane after the proteins were transferred from gel to
membrane in 3.5 minutes. Figure 3.5 showed the proteins bands on the membranes after the
proteins were transferred from gel to membrane in 4.5 minutes.
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Figure 3.4: Proteins were Transferred from Gel to PVDF Membrane in 3.5 Minutes and
p21 Signals were Detected
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Figure 3.5: Proteins were Transferred from Gel to PVDF Membrane in 4.5 Minutes and
p21 Signals were Detected
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Based on the results in Figure 3.4, when transferring proteins from gel to PVDF
membrane in 3.5 minutes, the p21 signals were obtained very clearly. The UV samples (lanes 34) also showed a significant increase in p21 signals compared with the No UV samples (lanes 56) as expected. Therefore, the optimal transferring time was determined to be 3.5 minutes using
the P3 program on the iBlot Dry Blotting System.

3.3.2. Second Experiment Parameter: Primary and Secondary Antibody Concentration
It is important to optimize the primary and secondary antibody concentration to produce the best
possible signals. If too little antibodies were used, the p21 signals may be too faint. If too much
antibodies were used, it may result in non-specific binding of antibodies. Therefore, an antibody
titration experiment Dot blot was performed to determine the optimal concentration of antibody.
Two micro litters of proteins from HELA sample were placed as dots on the PVDF membranes
as dots and different combination of primary and secondary antibodies were tested on each dot.
The p21 primary antibody used was the p21 rabbit polyclonal antibody from GeneTex (catalog
# GTX27960). The p21 primary antibody was mixed with the antibody diluents mix from
Invitrogen iBlot Western Detection Kit. The secondary antibody used was anti-rabbit antibodies
and were provided with the Invitrogen iBlot Western Detection Kit. The secondary antibody
was also mixed with the antibody diluents mix from the Invitrogen kit. After adding the
antibodies, the membrane was developed using the chromogenic solution from Invitrogen iBlot
Western Detection Kit. Different combinations of primary and secondary antibodies were
tested and the membrane strips were shown as in the Figure 3.6 below.
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Figure 3.6: Antibody Titration on Dot Blot Membrane
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From the antibody titration results as shown in Figure 3.6, it was determined that the
combination of 1:200 primary antibody and 1:1000 secondary antibody would give the best p21
signals on a PVDF membrane (strip 2). Therefore, in the final Western blot protocol, this
combination of antibodies concentrations were used to detect p21 proteins among different
samples.

3.3.3. Third Experiment Parameter: Developing Time
After the primary and secondary antibodies were added to the PVDF membrane, p21 proteins
were still not visible until the chromogenic solution was added to the membrane. The enzymes
on the secondary antibodies react with the substrates in the chromogenic solution and form
visible bands on the membrane. The period during which the PVDF membrane was incubated
with the chromogenic solution is called the developing time. If the developing time is too short,
the p21 signals may be very faint. If the developing time is too long, it may result in a high back
ground noise, which in turn makes it harder to recognize the signals and compare the signals
among different treatments. Different developing time periods were tested. These include 15
minutes, 30 minutes and 60 minutes (1 hour). The results are shown in Figures 3.7, 3.8, 3.9
below. Based on the results in Figure 3.8, developing time 30 minutes showed the best p21
signals with a minimal background noise on the PVDF membrane. Therefore, developing time
30 minutes was implemented in the final Western blot protocol.
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Figure 3.7: PVDF Membrane was Developed in 15 Minutes
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Figure 3.8: PVDF Membrane was Developed in 30 Minutes
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Figure 3.9: PVDF Membrane was Developed in 60 Minutes
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Chapter 4: Methods
4.1. Overview of the Experiment Process

Step 2: Skin Cells were grown in
four 6-well Plates

Step 1: Prepare Cell Media that contains
1% milk phospholipids concentrate

Step 3: Total Cells Proteins
were extracted
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Step 4: Cell Proteins were denatured by
SDS detergent

Step 5: Proteins were separated by Their Sizes
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Step 6: Antibodies was used to detect protein p21 and ImageJ
software was used to analyze the p21 signals
Figure 4.1: Overview of Western Blot Assay (KOMABIOTECH 2014)
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4.2. Milk Phospholipids Preparation
Milk phospholipids concentrate (PC-700, Fonterra Limited, Edgecumbe, New Zealand)
was tested in this study. This mixture contains complex phospholipids with high levels of
sphingomyelin extracted from bovine’s milk fat globule membrane and concentrated at levels
5000 times higher than that normally found in milk. The milk phospholipids powder was shown
in Figure 4.2 below. A solution of 1% (w/v) of milk phospholipids was prepared by mixing 0.5
g of the milk phospholipids powders into 50 mL of the cell culture maintainance media (EPI100-NMM, MatTeK Corporation, Ashland, MA) in a conical tube. After that, the tube was put
into a 550C water bath for about 20 minutes until all the solids are completely dissolved. The
solution was then filtered 2 times using a 10 cc syringe and 0.45 µm, 0.2 µm syringe filters.

Figure 4.2: Milk Phospholipids Powder
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4.3. Samples Preparation and Incubation
In this study, human skin cells keratinocytes were purchased from and used in the
experiments. Keratinocytes cells were grown in a 370C, 5% CO2 incubator and reached 90%
confluent in four 6-well plates. The four 6-well plates were labeled as No UV, UV, MP + UV,
and MP as shown in Figure 4.3. The No UV plate contains cell samples that will not be treated
with UV light. The UV plate contains cell samples that will be exposed to UV light. The MP +
UV plate contains cell samples that will be treated with milk phospholipids for 24 hours first
then exposed to UV light. The MP plate contains cells that will be treated with milk
phospholipids for 24 hours. First, the MP+UV and MP plates were taken out of the incubator and
placed in the sterile laminar hood. The cell media solutions were removed from all wells of these
2 plates. Then, 1.5 mL of the 1% milk phospholipids solution was added to each well. After that,
the 2 plates were brought back and incubated in the 370C, 5% CO2 incubator for 24 hours.
After 24 hours of incubation, the UV and MP+UV plates were transported from the
incubator to the sterile hood for UV treatment. The UV lamp UVP EL Series, UVL-28 Lamp
(UVP, LLC, Upland, CA) was disinfected with 70% ethanol then transported inside the hood and
warmed up by turning the power to the setting 302 nm for 10 minutes. The UV detector
ThorLabs Optical Power Meter (Thorlabs, Newton, NJ) used to measure the UV wattage reading
from the UV lamp was also disinfected and brought inside the sterile hood. The exposure time
for a 10 mJ/cm2 UV dosage was calculated using the area of the detector 0.7088 cm2 and the
average wattage reading 0.242 mJ/s. The exposure time was calculated using the following
formula.
Exposure Time = (Desired Dose)(Area of Detector) / (Average wattage)
= (10 mJ/cm2)(0.7088 cm2) / (0.242 mJ/s) = 29 (seconds)
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After UV exposure, both plates UV and MP+UV were transported back to the 370C, 5% CO2
incubator immediately and incubated for 24 hours. The No UV plate contained cells that were
not exposed to UV and the MP contained cells that were treated with 1% milk phospholipids
were also incubated in the incubator for another 24 hours.

Figure 4.3: Four 6-Well Plates Containing Human Keratinocytes Under Different
Treatments-UV, NO UV, Milk Phospholipid+UV, and Milk Phospholipid

4.4. Total Cells Protein Extraction Using SDS Lysis Buffer
The next step in the experiment is to extract all proteins from cells. After 24 hours of
incubation, all 4 plates were taken out of the incubator and the cell media was taken out of all
wells. Each plate was then washed with PBS one time. A 0.1% SDS (w/v) lysis buffer was
prepared freshly according to the recipe in the appendix. Then, 100 µL of lysis buffer is added to
each well. The keratinocyte cells from 4 plates No UV, UV, MP+UV and MP were then
scrapped off from the wells and transferred to four different 1.5 mL centrifuge tubes. The 4
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centrifuged tubes were kept on ice at all times. After that, 4 tubes containing cells were put on an
orbital shaker for 30 minutes. Then, the 4 tubes were centrifuged at 12,000 RPM for 30 minutes
in a 40C cold room. The centrifugation process separated the proteins from other cell debris.
After the centrifugation process, total cells proteins were present at the top of the centrifuged
tubes, in the supernatant. The cell debris parts were at the bottom of the centrifuge tubes, in the
white pellet. After 30 minutes centrifuged, the supernatants were removed and kept in 4 new
centrifuge tubes as shown in Figure 4.4 below.

Figure 4.4: Four Centrifuge Tubes Containing Extracted Proteins in the Supernatant and
Cell Debris in the Pellet

4.5. Quantification of Total Cell Protein Concentration Using BCA Assay
BCA assay, also known as Bicinchoninic Acid Assay, is a very common technique used
to measure the protein concentration in different samples. The BCA assay involves measuring
the absorbance at 562 nm of a series of known protein concentrations. Then, a standard linear
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curve illustrating the relationship between proteins’ absorbance at 562 nm and protein
concentrations is generated. The unknown concentration of the sample protein is determined by
interpolating from the standard linear curve that was constructed previously. In this experiment,
the BCA assay was employed to quantify protein concentration of total proteins extracted from 4
different samples No UV, UV, MP+UV and MP. The BCA method was adapted from the Pierce
Microplate BCA Assay Kit – Reducing Agent Compatible (Pierce). In order to minimize the
amount of sample proteins needed for this assay, the protein assay was performed on a 96-well
microplate. First, a series of known concentration of BSA (Bovine Serum Albumin) proteins was
prepared from the stock BSA solution 2 mg/mL as in Table 4.1.
Vial

PBS volume (µL)

BSA source (µL)

Concentration (µg/mL)

A

0

200 of Stock

2000

B

66

200 of Stock

1500

C

100

100 of Vial A

1000

D

100

100 of Vial B

750

E

100

100 of Vial C

500

F

100

100 of Vial D

250

G

100

100 of Vial F

125

Table 4.1: Protein Standard Samples in the BCA Assay
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After the preparation of different concentrations of BSA samples, the BCA working reagent was
prepared using the following formula.
Working Reagent = (# controls + # standards + # unknowns) x (2 replicates) x (0.26 mL)
In this experiment, the volume of the working reagent was calculated as the following.
Working Reagent = (2 controls + 7 standards + 16 uknowns) x (2 replicates) x (0.26 mL)
= 17.68 mL
The working reagent is made by mixing Reagent A and Reagent B (included in the Pierce BCA
Assay Kit) according to the 50:1 ratio. Therefore, 18 627 µL of reagent A was mixed with 373
µL of reagent B to yield 19 000 uL or 19 mL of working reagent with a clear green color.
The next step is to prepare a series of different dilutions 1:10, 1:15, 1:20 and 1:30 of 4 unknown
protein samples: No UV, UV, MP+UV and MP. After that, 9 µL of each replicate of the BSA
standards, unknown samples, and the control PBS samples was added to the center of each well
in the 96-well microplate. Then, 260 µL of the working reagent was added to each well. The 96well microplate was then covered with a plastic wrap and incubated in a 370C incubator for 30
minutes. After the incubation time, the plate was cooled down at room temperature for 5
minutes. The absorbance of different protein samples in the plate was now ready to be read by
the SPECTRAmax PLUS384 UV/Vis spectrophotometer (Molecular Devices, Sunnyvale, CA).
The spectrophotometer was turned on and warmed up for 15 minutes before; the wavelength was
also set to 562 nm. The 96-well microplate was put inside the plate holder then the absorbance of
protein samples at 562 nm was measured by selecting the “Read Plate” button on the computer
software. The absorbance at 562 nm of all the protein samples in the plate was then displayed on
the computer screen. The readings of a series of known concentration of BSA were used to
create a linear standard curve with y corresponds to the absorbance at 562 nm, and x corresponds
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to the protein concentration in µg/mL. An equation illustrating the relationship between
absorbance and concentration in the form of y = ax + b was obtained from the standard curve.
The concentration of the unknown protein sample was calculated by plugging the absorbance
value into y to find the concentration x.

4.6. Sodium Dodecyl Sulfate Polyacrylamide (SDS-PAGE) Gel Electrophoresis
The SDS-PAGE gel is commonly used to separate proteins based on their molecular
weights. In this experiment, a commercial pre-cast gel, Invitrogen NuPAGE Novex 4-12% BisTris gel, catalog # NP0335BOX, was used. First, the white tape at the bottom of the pre-cast
NuPAGE gel cassette was removed and the cassette was inserted into the Invitrogen XCell
SureLockTM Mini-Cell Electrophoresis, catalog # EI0001 (Invitrogen). The tank was then filled
with running buffer (recipe in the Appendix) up to the fill line. After setting up the gel apparatus,
the next step was to prepare protein samples before loading into the gel. From the BSA protein
assay, the unknown concentrations of different protein samples were determined. The UV
sample had a concentration of 4176 µg/mL, the No UV sample had a concentration of 9484
µg/mL, the MP + UV sample had a concentration of 13663 µg/mL and the MP sample had a
concentration of 10759 µg/mL. To compare the expression of p21 proteins, the same amount of
protein 145 µg from each sample would be loaded into each well as in the following table.
Before loading the samples into the gel, the samples were mixed with NuPAGE LDS sample
buffer (4X) and distilled water according to the recommendation in Table. Then samples were
put into a 900C bath for 10 minutes, so that the native globular structures of proteins would be
denatured into linear structures. Once all proteins were denatured into linear molecules, they
could be separated based on their size or molecular weights on a SDS-PAGE gel. Molecular
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weight marker (MW marker) contained 10 different proteins with known molecular weights. By
comparing the mobility of these known 10 proteins in the MW marker, researchers could
determine the molecular weight of the protein of interest. In this experiment, the Bio-Rad
Precision Plus Protein Standards, catalog # 161-0373, was used as the MW marker (Bio-Rad).
The HELA (Human Epithelial Carcinoma Cell Line), Whole Cell Lysate from Abcam, catalog #
ab150035 was used as a positive control for p21 proteins (Abcam). The molecular weight marker
and the protein samples were loaded into different lanes of the gel as shown in Table 4.2 below.
Sample buffer and water were also added to the protein samples and loaded on the gel. Table 4.3
showed the amount of sample, sample buffer and water that were added into each lane of the gel.
Lane
1

Lane
2

Lane
3

Lane
4

Lane
5

Lane
6

Lane
7

Lane
8

Lane
9

Lane
10

Sample

MW
marker

Blank

Blank

UV 4

No
UV 4

MP +
UV

MP

HELA

Blank

Blank

Protein (µL)

10

0

0

35

15

11

14

10

0

0

Table 4.2: Summary of Different Samples Loaded in the Gels

Reagent

Reduced Sample Volume
(μL)*
10
2.5

Sample
NuPAGE LDS Sample Buffer
(4X)
Distilled H2O
6.5
TOTAL VOLUME
20
* Volumes can be adjusted according to the desired loading volumes.
®

Table 4.3: NuPAGE® Novex Bis-Tris Mini Gel Sample Preparation Guide
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The red and black cables then were plugged in then the “Run” button was selected. The gel
electrophoresis apparatus was run at 200V for about 45 minutes until the blue dye front reached
the bottom of the gel. There should be rising bubbles coming from the bottom of the gel as soon
as the “Run” button was selected and during the gel electrophoresis process. If there was no
bubbles coming up, cables connection and gel apparatus setup should be checked. After the gel
electrophoresis was complete, the gel apparatus was disconnected and disassembled. The gel was
removed and the cassette was cracked open by using a gel knife. The gel was placed into distilled
water for the protein transferring process afterward. The gel electrophoresis set up was shown in
Figure 4.5 below.
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Figure 4.5: Gel Electrophoresis Process

4.7. Protein Transferring from the Gel to the PVDF Membrane
While the gel was running, the IBlot 7-Minute Blotting System machine (Invitrogen,
catalog # 1001) was turned on and warmed up for 10 minutes (Invitrogen). The program P3 and
running time 3.5 minutes were selected on the machine. Figure 4.6 showed a picture of the IBlot
7-Minute Blotting System machine that was used.
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Figure 4.6: Invitrogen iBlot Gel Transfer Device
The iBlot Transfer Stack, PVDF mini (Invitrogen, catalog # IB4010-02) was used to transfer
proteins from the gel to a PVDF membrane. A complete transfer stack consists of one anode and
one cathode stack. First, the lid of the iBlot Gel Transfer Device was opened up. Second, the
anode stack was unsealed and the stack was kept in the plastic tray. Third, the anode stack (in the
plastic tray) was placed on the blotting surface of the Iblot Gel Transfer Device. Then, the gel
was placed on the transfer membrane of the anode stack. After that, an iBlot filter paper was
soaked in distilled water and placed on top of the gel. All the air bubbles were removed using a
blotting roller. Next, the cathode stack was unsealed and placed on top of the blotting pre-soaked
filter paper. All the air bubbles were again removed by using a blotting roller. Then, a disposable
sponge with the metal contact was placed on the upper right corner of the lid. Finally, the lid was
closed and the latch was secured in place. At this time, a red light would be on to indicate that a
closed circuit was achieved. The protein transferring process was then started by pressing the
“Start/Stop” button on the machine. The red light would then change to green light to indicate
that the protein transferring process was happening. At the end of the transferring process, the
current would automatically shut off, followed by a beeping sound and a flashing red light. After
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that, the “Start/Stop” button was pressed, the lid was opened and the iBlot gel transfer stack was
removed. The disposable sponge and the cathode stack were discarded. The anode stack,
containing the PVDF membrane, was kept in the red plastic tray for the western immunoblotting
procedure following immediately. Figure 4.7 showed how the proteins were transferred from gel
to the membrane underneath it using the IBlot 7-Minute Blotting System machine.

Figure 4.7: The Process of Protein Transferring from a Gel to a PVDF Membrane

4.8. Western Immunoblotting Detection Procedure
The first step of the western immunoblotting detection procedure would be to prepare
solutions to detect p21 signals on the PVDF membrane. First, the wash solution was diluted by
mixing 6 mL of wash solution (included in the Invitrogen detection kit) with 90 mL of distilled
water. Second, the antibody diluents mix was prepared by mixing 4.5 mL of antibody diluents
additive with 10.5 mL of antibody diluents solution. Third, the primary antibody solution was
prepared by mixing p21 primary antibody (GeneTex, rabbit polyclonal antibody, catalog #
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GTX27960) with 5 mL of antibody diluents mix (GeneTex). Fourth, the secondary antibody was
prepared by mixing secondary antibody (included in the Invitrogen detection kit) with 5 mL of
the antibody diluent mix. Finally, 5 mL of the chromogenic substrate (included in the Invitrogen
detection kit) was poured into a 50 mL conical tube.
After all the solutions were prepared, the antibodies could now be ready to be applied to
the PVDF membrane to detect the presence of p21 proteins. The Western Detection kit,
containing the top and bottom stacks, would be used to detect p21 signals. First, the program on
the iBlot Gel Transfer Device was selected to be P3 and 3.5 minutes and the lid was opened.
Second, the antibody diluent solution was applied evenly on a white matrix in a small plastic
case. Third, the iBlot Western Detection Stack Bottom was unsealed and placed on top of the
blotting surface of the iBlot Gel Transfer Device. Then, the PVDF membrane, with the protein
side facing up and laying on top of the iBlot Gel Transfer Anode Stack, was removed using a
clean pair of forceps and placed on top of the Western Detection Stack Bottom. All the bubbles
were removed using a blotting roller. After that, the white matrix that was pre-soaked with
antibody diluent solution was placed on top of the PVDF membrane. Any bubbles created were
removed using a blotting roller. The iBlot Western Detection Stack Top was unsealed and placed
on top of the white matrix, with the electrode side facing up. The iBlot Disposable Sponge was
placed so that the metal contact was at the right corner of the lid. The lid was closed, the latch
was secured and the red light was on to indicate a closed circuit. The “Start/Stop” button was
selected and the red light changed to green. While the iBlot device was running, 5 mL of the
primary antibody solution was applied to a new matrix. After 2 minutes, there were a beeping
sound and a flashing green light to indicate that the blocking step ended. The lid was then opened
but the sponge was still left in place. The top stack was then removed and set aside in the red
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plastic tray for re-use in the next step. The used blocking solution matrix was discarded. The new
matrix that was pre-soaked with the primary antibody was placed onto the membrane. All the
bubbles were then removed with a blotting roller. After that, the top stack was returned to its
position over the matrix and all the bubbles were removed with a blotting roller. The lid was
closed and the latch was secured. The “Start/Stop” button was selected to start the process of
applying primary antibody to the PVDF membrane. While the iBlot device was running, 5 mL of
the secondary antibody solution was then applied onto a new matrix. After 3 minutes, the device
stopped; there were a beeping sound and a flashing green light to indicate the end of the primary
antibody step. The lid was opened but the sponge was still left in place. The top stack was
removed and set aside in the red tray for re-use in the next step. The used primary antibody
matrix was discarded. The new matrix that was pre-soaked with the secondary antibody solution
was placed on top of the membrane. All the bubbles were removed using a blotting roller. The
top stack was returned to its position over the matrix and all the bubbles were removed again
using a blotting roller. The lid was closed and the latch was secured. The “Start/Stop” button was
pressed to start the process of applying the secondary antibody to the PVDF membrane. After 3
minutes, the device stopped. There were a beeping sound and a flashing red light to indicate the
end of the transfer procedure. The lid was then opened and the sponge was discarded. The used
matrix, top and bottom stacks were also discarded. The iBlot device was turned off. The next
step in the procedure was to wash the PVDF membrane.
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4.9. Washing the Membrane
The membrane was first placed into a min-sized dish (provided in the kit) containing 20
mL of the 1X wash solution. The membrane was rinsed briefly and the solution was discarded.
The PVDF membrane was washed for 5 minutes with 20 mL of 1X wash solution then the
solution was discarded. This wash step was repeated two more times. The membrane was then
rinsed with 20 mL of deionized water then the water was decanted. This wash step was repeated
one more time.

4.10. Chromogenic Detection to Detect p21 Signals
After the wash step, the p21 signals on the membrane were detected using the chromogenic
detection method. The membrane with the protein-side facing up was first placed in a plastic
tray. Five millimeters of the chromogen reagent was measured in a cylinder. Then, the
chromogen solution was poured over to cover the entire PVDF membrane. The plastic tray
containing the membrane was put on a shaker. The membrane was incubated with the
chromogenic substrate for 30 minutes until the desired purple band intensity was obtained on the
membrane. This reaction was stopped by rinsing the membrane briefly with 20 mL of distilled
water for 2 minutes. This 2 minute water rinse step was repeated 2 more times. The membrane
was then air-dried and placed on a clean piece of filter paper.

4.11. Visualization of p21 Signals on the PVDF Membrane
The PVDF membrane was placed in the center of the ChemiDocTM XRS+ System
chamber. The White Light option was turned on and the image of the membrane was focused to
achieve the best resolution on the computer screen. After that, the image of the membrane was
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saved as a TIF file and the intensity of the interested protein bands was analyzed later using
ImageJ software.

4.12. Analysis of p21 Protein Bands Using ImageJ Software
The western blot membrane image was first opened in ImageJ software and converted to
the 8-bit mode by selecting Image-Type-8 bit. Then, the “Rectangle Selections” tool from the
ImageJ toolbar was selected to draw a box around the first lane. After that, the command
“Analyze-Gels-Select First Lane” was chosen to set the rectangle in place, the first lane was then
highlighted and a number “1” appeared in the middle of it. Then, the mouse was used to click
and hold in the middle of the rectangle of the first lane and drag over to the next lane. The
command “Analyze-Gels-Select Next Lane” was selected to place a rectangle over the 2nd lane.
The second lane was then highlighted and a number 2 appeared in the middle of that lane. The
same process was repeated until all 5 lanes were highlighted with a rectangle and numbered.
After the last lane was highlighted, the command “Analyze-Gels-Plot Lanes” was selected and
the profile plot of each lane would appear. Then, the “Straight Line” command was selected and
a line was drawn across the base of each peak to enclose the peak. After all of the peaks were
closed off at the base using the “Straight Line” selection tool, the “Wand” tool was then selected
and used to click inside the peak. Each peak was then be highlighted and the area measurements
of the peaks would show up in the “Results” window. The area measurement of each peak
corresponded to the intensity of the p21 protein band in each sample. The area measurement data
was copied and pasted into Microsoft Excel. The density of the second peak, corresponding to
the intensity of p21 protein band in the No UV sample, was chosen as the standard with the
relative density of 1. The relative density of p21 protein bands in other samples were calculated
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by dividing the area measurement for each peak by the area of the No UV peak (Miller 2010).
The relative densities or the intensities of p21 protein bands in all samples were recorded in
Table 5.2.
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Chapter 5: Results

5.1. Molecular Weight of p21 Bands on Western Blot Membrane
The molecular weight of p21 protein bands on the western blot membrane was
determined by comparing the migration distance of p21 protein bands with the migration
distance of standard proteins (known molecular weight).
Eight standard proteins with known molecular weight were loaded into the first lane of
the gel and run under the same conditions with p21 proteins from the 5 samples UV, No UV,
UV+MP, MP and HeLa. After proteins were transferred from the gel to the PVDF membrane,
and the p21 proteins signals were developed, the migration distance of standard proteins and p21
protein bands was measured from the top of the membrane and recorded in Table 5.1.
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Table 5.1: The Log MW of Proteins and Their Respective Migration Distance (mm)
Standard Proteins
MW (KDa)

Log MW

Migration Distance (mm)

100

2

23

75

1.875061

29

50

1.69897

38

37

1.568202

44

25

1.397794

52

20

1.30103

54

15

1.176091

59

10

1

63

MW

Log MW

Migration Distance (mm)

62.34

1.7948

33

Unknown Protein

Then, a standard curve of Log MW of standard proteins vs. migration distance (mm) was
created in Microsoft Excel as shown in Figure 5.1.
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Figure 5.1: The Standard Curve of Log MW vs. Migration Distance (mm)

Y = (-0.024)(33) + 2.5868 = 1.7948
MW = 10(1.7948) = 62.34 ~ 63 KDa

From the standard curve, a linear relationship between Log MW of standard protein
markers and migration distances was obtained and described as Y = -0.024x + 2.5868 with Y
corresponds to Log MW and X corresponds to migration distance. The R2 value is 0.9849,
which is very close to 1. This suggests a very strong positive linear relationship between Log
MW and migration distance.
The molecular weight of the unknown protein bands showed up in Lane 4-Lane 8 was
determined by using the formula Y = -0.024x + 2.5868. Since the migration distance of the
unknown proteins is 33 mm, the value of X is replaced as 33 and the value of Y is calculated as
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1.7948. Since Y value corresponds to Log of molecular weight, the molecular weight is
calculated as around 63 KDa.
Y = (-0.024)(33) + 2.5868 = 1.7948
Y = Log MW. Therefore, MW = 10Y = 10(1.7948) = 62.34 ~ 63 KDa.
It is concluded that the unknown protein band corresponds to a multimer of p21 protein.
Specifically, three p21 proteins covalently bonded with each other and traveled as a 63 KDa
molecule on the gel and on the PVDF membrane. Since the gel was run under denatured and
non-reducing conditions, p21 proteins were free to make covalent bonds with each other and
formed a multimer of p21 as seen on the membrane.

5.2. Analysis of the Intensity of p21 Protein Bands
The intensity of p21 protein bands from 5 different samples UV, No UV, UV+MP, MP
and HeLa was analyzed using ImageJ software and the generated results were shown as in
Figure 5.2. The area under each peak corresponds to the intensity of p21 protein band from
different samples.
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Peak 1: Intensity of p21 Proteins in UV Sample

Peak 2: Intensity of p21 Proteins in No UV Sample

Peak 3: Intensity of p21 Proteins in UV+MP Sample

Peak 4: Intensity of p21 Proteins in MP Sample

Peak 5: Intensity of p21 Proteins in HeLa Sample

Figure 5.2: ImageJ Analysis of the Intensity of p21 Protein Bands
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Figure 5.3: Western Blot Membrane Shows p21 Protein Levels in Different Samples
Sample 1 – UV, sample 2 – No UV, sample 3 – UV+MP, sample 4 – MP, sample 5 –
HELA
Lane

1
Sample

2
MW

3

Blank

4

Blank

5
UV

6

No UV

7
UV +

8

9

10

MP

Hela

Blank

Blank

MP

[Protein] (µg/mL)

N/A

0

0

4176

9484

13663

10759

2000

0

0

Amount of

N/A

0

0

145

145

145

145

2

0

0

10

0

0

35

15

11

14

10

0

0

Protein (µg)

Sample Vol (µL)
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To compare the intensity of p21 protein bands among 5 samples UV, No UV, UV+MP,
MP and HeLa as shown in Figure 5.3, the area under the peak of p21 protein band from the No
UV sample was normalized to 1. Then, the area under the peak of p21 protein band from
different samples was divided by the area from the No UV sample, 8018.731. As a result, the
relative densities of UV, No UV, UV+MP, MP and HeLa were 2.28, 1, 1.13, 0.948, and 1.236
respectively and were shown in Table 5.2.

Sample

Area

Relative Density

No UV

8018.731

1.00

UV

18308.572

2.28

UV + MP

9041.338

1.13

MP

7604.296

0.948

HeLa

9907.995

1.236

Table 5.2: Analysis of p21 Protein Levels in Different Samples Using ImageJ Software. UV
– Ultraviolet Light Radiation, MP-Milk Phospholipids, HeLa – Human Epithelial
Carcinoma Cell Line
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Chapter 6: Discussion and Conclusion
6.1. Discussion
Under non-reducing conditions, three p21 proteins covalently bonded with each other
showed up as 63 KDa molecules on the PVDF membrane. The UV and HeLa samples showed a
2.28 fold and 1.23 fold increase in p21 expression, respectively, compared to the No UV sample
control. The MP sample showed a 0.948 fold decrease in p21 expression and the UV+MP sample
showed only a 1.13 fold increase in p21 expression compared with the No UV sample control.
By comparing with the UV sample, the UV+MP sample has 50.4% less p21 expression. The MP
sample also has only 5% less p21 expression compared with the No UV sample. This small
difference in p21 expression showed that milk phospholipids do not interfere and affect cellular’s
normal physiological activities negatively. Less p21 expression in the UV+MP sample compare
with the UV sample suggested that less DNA damage occurred in the sample that was treated
with milk phospholipids. This result strongly suggests that bovine milk phospholipids can protect
skin cells from UV induced DNA damage.
The mechanism of how bovine milk phospholipids can protect human skin cells from
DNA damage caused by UVB light exposure is still not clear and further research needs to be
done to investigate the details of the mechanism. In a research study done by Haruta-Ono et al. in
2012, they found that when radiolabeled sphingomyelin was orally administered to mice for
eight weeks, the sphingomyelin was incorporated in to skin sphingolipids and involved in the
water-holding capacity of the stratum corneum layer in the epidermis (Haruto-Ono 2012). Based
on this research study, it is most likely that the human skin cells probably absorbed milk
phospholipids in the cell media and incorporated these phospholipids in the skin cells
membranes. This created a better and stronger protective barrier against UV radiation and
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reduced DNA damage in the nucleus. Another possible explanation for a decrease of p21
expression in UV+ MP sample can be that the milk phospholipids interact with the cellular
membranes and affect the p53 → p21 signaling pathway to arrest the cell cycle at G1 to repair
DNA damage. However, more research studies need to be done to elucidate the mechanisms of
how milk phospholipids decrease p21 expression and to provide more evidence that a decrease in
UV-induced DNA damage is associated with a decrease in p21 expression. Future research
studies should investigate the expression of p53, a tumor suppressor protein, p48 and Gadd45,
DNA damage repair proteins. Protein p53 expression is increased after cells are exposed to UV
radiation. Proteins p48 and Gadd45 are induced by the expression of p53. These are important
proteins involved in the DNA damage repair pathways in cells as a response to UV-induced
DNA damage. Proteins p48 and Gadd45 recognize and bind to damaged DNA and trigger the
DNA damage repair cascades. If milk phospholipids actually protect skin cells from less DNA
damage induced by UV radiation, it is expected that a decrease in p21, p53, p48 and Gadd45
expressions would occur in UV+MP sample compared with the UV sample. This will provide
stronger evidence that milk phospohilipids protect cells from UV-induced DNA damage. Future
research studies could also investigate the optimal milk phospholipids concentration that can
protect skin cells from UV-induced DNA damage most effectively.
This thesis project shows a working Western blot protocol that can be used to investigate
the expression of p21 and the protective effects of milk phospholipids against UV-induced DNA
damage in keratinocytes. This protocol can be optimized to study the expression of p21 in the
future by increasing the reducing reagent concentration in all samples to ensure that p21 proteins
are reduced completely and will appear as 21 KDa molecules instead of as a trimmer 63 KDa on
the PVDF membrane in this research study. Running buffer used to run gel electrophoresis
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should be new and fresh to make sure that all protein samples are run under reducing conditions.
This will prevent p21 proteins to cross link and form trimmers.
Moreover, the protocol used in this study serves as a framework for future Western blot
protocols to build on to investigate the expression of other biomarkers involved in cellular
pathways as a response to UV radiation. The optimal UV dosage to induce p21 expression was
determined to be 10 mJ/cm2. It is expected that the same UV dose can induce p53 expression
because p21 is a downstream proteins of p53. If p53 expression is induced at 10 mJ/cm2, it is
expected that p48 and Gadd45 proteins were also induced at 10 mJ/cm2 because they are the
downstream proteins of p53. The minimum cells needed for each sample treatment was
determined to be 6 wells (1 plate) of keratinocytes and the optimal incubation time post UV
exposure was found to be 24 hours. The same approach can also be used to determine the
optimal transferring time by testing different transferring time intervals on gel strips containing 2
lanes. The primary and secondary antibodies concentrations can be optimized using the antibody
titration on dot blot membrane. In order to obtain the best proteins signals with a minimal
background noise on a PVDF membrane, the developing time is expected to be around 30
minutes when investigating other biomarkers as well. Chapter 2 provides very details of the
approach to optimize different experiment parameters in Western blot assay and can be useful in
the development of other Western blot protocols to study different cellular biomarkers.
The results from this thesis project suggest that milk phospholipids have protective
effects against UV-induced DNA damage in keratinocytes. More research studies should be done
to investigate the expression of other cellular biomarkers to elucidate the mechanism of how
milk phospholipids protect human skin cells against UV radiation damage.
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6.2. Conclusion
Bovine milk phospholipids (1%) solution showed that it can decrease 50.4% of p21
expression in human skin cells after exposing to UV radiation. A lower p21 expression suggested
that less UV-induced DNA damage occurred in keratinocytes that were treated with milk
phospholipids compared with the keratinocytes that were not treated. It is hypothesized that
human skin cells may uptake the milk phospholipids and incorporate them into the cell
membrane. This created a stronger and better physical barrier against UV damage. To gain a
better understanding about the mechanism of how bovine milk phospholipids protect skin cells
against UV radiation damage, future research studies should investigate on the expression of
other biomarkers such as p53, tumor suppressor protein, p48 and Gadd45, proteins involved in
DNA damage repair mechanisms. With more evidence about its protective effect against UV
damage, bovine milk phospholipids can potentially be a chemopreventive agent. It can also
possibly be incorporated into different sunscreen and nutritional products.
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Appendix

2% SDS Lysis Buffer (50 mL), store at -20oC (Adapted from Zyra 2011) (Achay 2011)
0.394 g Tris-HCl (0.05 M), pH = 8.0
1 g (2% w/v) SDS
0.077 g (10 mM) DTT (dithiothreitol)
0.002 g (0.01 mM) EDTA (ethylenediaminetetraacetic acid) or 20 µL from 500 mM stock
solution
0.009 g (1 mM) PMSF (phenylmethylsulfonyl fluoride)* or 200 µL from a 500 mM stock
solution
1 tablet Complete mini protease inhibitor cocktail* (Roche, Indianapolis, IN)
Dilute to 50 mL with ddH2O
* add components immediately prior to use

107

